GlassScriptPhysician profile
Luvell L Glanton
NPI 1891717781
$32,579.31
in general payments reported to CMS, 2019-2025
20 companies · $3,321 in 2025
The $3,321 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,878 · 2020: $2,191 · 2021: $3,049 · 2022: $14K · 2023: $2,956 · 2024: $1,480 · 2025: $3,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,095 · Consulting Fee: $1,313 · Travel and Lodging: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,094.70 |
| Consulting Fee | $1,312.50 |
| Travel and Lodging | $348.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19,572.91 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $4,528.45 | 2021-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $4,449.57 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $1,557.99 | 2022 | |
| Globus Medical, INC. | $797.20 | 2025 | Senza, Vyrsa V1 |
| Medtronic USA, INC. | $729.14 | 2019-2020 | |
| Relievant Medsystems, INC. | $171.06 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $141.84 | 2019 | |
| Vertiflex, INC. | $109.71 | 2019 | |
| Spr Therapeutics, INC | $102.16 | 2022-2023 | Sprint Pns System |
| Tersera Therapeutics LLC | $91.20 | 2019-2022 | |
| Pfizer INC. | $71.15 | 2019-2021 | |
| Foundation Fusion Solutions, LLC | $67.60 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.47 | 2022 | |
| Daiichi Sankyo INC. | $34.38 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $30.73 | 2021 | |
| Abbvie INC. | $28.53 | 2022 | |
| Collegium Pharmaceutical, INC. | $23.77 | 2019 | |
| Celgene Corporation | $14.64 | 2019 | |
| Stryker Corporation | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luvell Glanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.